The NMR Resource provides instrumentation and software for acquiring and processing nuclear magnetic resonance (NMR) spectra, molecular modeling and three-dimensional biomolecular analysis, and acquiring and processing NMR data of biofluids (metabonomics). Two high-resolution NMR spectrometers (Bruker AMX-400 and AMX-600) operating at 400 and 600 MHz are available to qualified RPCI personnel 24 hours per day, seven days a week. For more occasional users, or for pilot programs developing and determining the potential utility of NMR techniques, NMR Resource personnel may perform all aspects of NMR sample acquisition, processing and data interpretation. Molecular modeling and three-dimensional biomolecular analysis occur as an extension of interpretation of the NMR data, or independent of pre-existing NMR data. In this latter case, computational studies are performed to predict biomolecular structures. The NMR Resource has five SGI and one SUN UNIX based workstations. Working with the RPCI Department of Information Technology, the NMR Resource has developed the capability of Internet access of NMR Resource data and has personal computers and software for processing NMR data within the NMR Resource or anywhere offsite. The capability exists for clients to run UNIX workstation-based NMR or modeling sottware on remotely located PCs. For client convenience, the NMR Resource also provides Intemet access of sign-up schedules for various instruments. The NMR Resource was used by 11 investigators with peer-reviewed funding during the twelve-month reporting period for this application and has contributed to 46 publications since 1999. It is anticipated that the use of this Resource will increase with the arrival of new recruits. The Resource is publicized through special seminars and meetings with CCSG Program Leaders and members.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-31
Application #
7417855
Study Section
Project Start
2007-05-01
Project End
2008-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
31
Fiscal Year
2007
Total Cost
$122,979
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Block, Matthew S; Vierkant, Robert A; Rambau, Peter F et al. (2018) MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clin Proc 93:307-320
Li, Qiuhui; Deng, Qu; Chao, Hsueh-Ping et al. (2018) Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nat Commun 9:3600
Rossetti, Stefano; Wierzbicki, Andrzej J; Sacchi, Nicoletta (2018) Undermining ribosomal RNA transcription in both the nucleolus and mitochondrion: an offbeat approach to target MYC-driven cancer. Oncotarget 9:5016-5031
Mett, V; Komarova, E A; Greene, K et al. (2018) Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy. Oncogene 37:439-449
Long, Mark D; Singh, Prashant K; Russell, James R et al. (2018) The miR-96 and RAR? signaling axis governs androgen signaling and prostate cancer progression. Oncogene :
Kawaguchi, Tstutomu; Yan, Li; Qi, Qianya et al. (2018) Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer. Ann Surg Oncol 25:4037-4046
Mussell, Ashley L; Denson, Kayla E; Shen, He et al. (2018) Loss of KIBRA function activates EGFR signaling by inducing AREG. Oncotarget 9:29975-29984
Hirose, Yuki; Nagahashi, Masayuki; Katsuta, Eriko et al. (2018) Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis. Sci Rep 8:10814
Vexler, Albert; Yu, Jihnhee; Zhao, Yang et al. (2018) Expected p-values in light of an ROC curve analysis applied to optimal multiple testing procedures. Stat Methods Med Res 27:3560-3576
Samuel, Sandeep; Mukherjee, Sarbajit; Ammannagari, Nischala et al. (2018) Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study. PLoS One 13:e0198809

Showing the most recent 10 out of 1555 publications